Impact of the COVID-19 pandemic on CVD prevention between different socioeconomic groups in Switzerland.
Détails
Etat: Public
Version: Final published version
Licence: CC BY-NC-ND 4.0
Document(s) secondaire(s)
Sous embargo indéterminé.
Accès restreint UNIL
Etat: Public
Version: de l'auteur⸱e
Licence: Non spécifiée
Accès restreint UNIL
Etat: Public
Version: de l'auteur⸱e
Licence: Non spécifiée
ID Serval
serval:BIB_A6A8509AA422
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Impact of the COVID-19 pandemic on CVD prevention between different socioeconomic groups in Switzerland.
Périodique
Open heart
ISSN
2053-3624 (Print)
ISSN-L
2053-3624
Statut éditorial
Publié
Date de publication
09/2023
Peer-reviewed
Oui
Volume
10
Numéro
2
Pages
e002368
Langue
anglais
Notes
Publication types: Journal Article ; Research Support, Non-U.S. Gov't
Publication Status: ppublish
Publication Status: ppublish
Résumé
The COVID-19 pandemic disrupted the continuing management of cardiovascular disease (CVD) risk factors in the population. Socioeconomic status (SES) is a major determinant of health. Whether the COVID-19 pandemic increased, the SES gap in CVD risk factors is unknown.
To compare the management of CVD risk factors and the SES gap before and during the pandemic.
Cross-sectional study conducted between 2018 and 2021 in Lausanne, Switzerland. Prevalence, awareness, treatment and control rates of hypertension, dyslipidaemia and diabetes were compared between the periods before (N=2416, 45.2% men, 65.3±9.8 years) and during (N=776, 44.5% men, 63.9±9.1 years) the COVID-19 pandemic. SES was defined by education and categorised as low (compulsory or apprenticeship), middle (high school) and high (university).
After multivariable analysis, the prevalence of hypertension increased, and awareness decreased during the pandemic: OR and (95% CI) 1.26 (1.04 to 1.53) and 0.70 (0.53 to 0.94), respectively. For dyslipidaemia, prevalence decreased during the pandemic 0.82 (95% CI 0.69 to 0.98); awareness did not change. For diabetes, prevalence did not change but awareness increased 5.76 (95% CI 1.23 to 27.04). No differences were found before and during the pandemic regarding treatment and control for all CVD risk factors. Relative to high SES, a decrease in hypertension awareness among middle SES categories was observed during the pandemic (OR and 95% CI 1.11 (0.73 to 1.69) before and 0.45 (95% CI 0.23 to 0.85) during, p for interaction<0.05), while no other changes were found.
Prevalence and management of CVD risk factors changed little during the pandemic. The SES gap did not increase except for hypertension awareness.
To compare the management of CVD risk factors and the SES gap before and during the pandemic.
Cross-sectional study conducted between 2018 and 2021 in Lausanne, Switzerland. Prevalence, awareness, treatment and control rates of hypertension, dyslipidaemia and diabetes were compared between the periods before (N=2416, 45.2% men, 65.3±9.8 years) and during (N=776, 44.5% men, 63.9±9.1 years) the COVID-19 pandemic. SES was defined by education and categorised as low (compulsory or apprenticeship), middle (high school) and high (university).
After multivariable analysis, the prevalence of hypertension increased, and awareness decreased during the pandemic: OR and (95% CI) 1.26 (1.04 to 1.53) and 0.70 (0.53 to 0.94), respectively. For dyslipidaemia, prevalence decreased during the pandemic 0.82 (95% CI 0.69 to 0.98); awareness did not change. For diabetes, prevalence did not change but awareness increased 5.76 (95% CI 1.23 to 27.04). No differences were found before and during the pandemic regarding treatment and control for all CVD risk factors. Relative to high SES, a decrease in hypertension awareness among middle SES categories was observed during the pandemic (OR and 95% CI 1.11 (0.73 to 1.69) before and 0.45 (95% CI 0.23 to 0.85) during, p for interaction<0.05), while no other changes were found.
Prevalence and management of CVD risk factors changed little during the pandemic. The SES gap did not increase except for hypertension awareness.
Mots-clé
Male, Humans, Female, Pandemics/prevention & control, Switzerland/epidemiology, Cross-Sectional Studies, COVID-19/epidemiology, Hypertension/diagnosis, Hypertension/epidemiology, Socioeconomic Factors, diabetes mellitus, epidemiology, hyperlipidemias, hypertension
Pubmed
Web of science
Open Access
Oui
Création de la notice
25/09/2023 17:37
Dernière modification de la notice
25/11/2023 8:08